Results 101 to 110 of about 33,357 (182)

Antidepressant-associated sexual dysfunction in outpatients. [PDF]

BMC Psychiatry
Safak Y, Inal Azizoglu S, Alptekin FB, Kuru T, Karadere ME, Kurt Kaya SN, Yılmaz S, Yıldırım NN, Kılıçtutan A, Ay H, Burhan HS.   +10 more
europepmc   +1 more source

Analysis of Reporting Trends of Serious Adverse Events Associated With Anti-Obesity Drugs. [PDF]

Pharmacol Res Perspect
Raičević BB, Belančić A, Mirković N, Janković SM.   +3 more
europepmc   +1 more source

Efficacy of pharmacological intervention for smokeless tobacco cessation in adults: a systematic review and meta-analysis. [PDF]

Arch Public Health
Pradhan S, Priyadarshini SR, Panda S, Misra SR, Panigrahi R, Choudhury BK.   +5 more
europepmc   +1 more source

Crisis convulsiva por bupropion [PDF]

Anales de Medicina Interna, 2005
Solano Remírez, M., Álvarez Frías, M. T., González Arencibia, C., Gutiérrez Dubois, J., Llorente Díaz, B.   +4 more
openaire   +3 more sources

Smoking, Obesity, and Post-Cessation Weight Gain: Neurobiological Intersection and Treatment Recommendations. [PDF]

J Multidiscip Healthc
Golden A, Davis JM.
europepmc   +1 more source

Cost-effectiveness analysis for implementation of smoking cessation strategies at primary health care settings in Tamil Nadu. [PDF]

PLoS One
Mahalingam V, Santhanakrishnan RK, Malaisamy M, Chelvanayagam K, Mathiyazhagan K, Bhaskar A, Nagarajan K, Maria Selvam J, Veeraiah S, Rajsekar K, Tyagi K, Chinnaiyan P.   +11 more
europepmc   +1 more source

Diethylpropion, Bupropion, and Psychoses [PDF]

British Journal of Psychiatry, 1988
openaire   +3 more sources

Comparison of the efficacy and safety of bupropion versus aripiprazole augmentation in adults with treatment-resistant depression: a nationwide cohort study in South Korea. [PDF]

Eur Psychiatry
Lee DY, Park RW, Jeon SM.
europepmc   +1 more source

Smoking Cessation Strategies After Acute Coronary Syndrome. [PDF]

J Clin Med
Nazir A, Shetty Ujjar S, Seddiki MO, Jheinga M, Fan L.   +4 more
europepmc   +1 more source

Potential Cardiovascular Risks Associated with Naltrexone-Bupropion Treatment in Overweight Patients [Response to Letter]. [PDF]

Drug Des Devel Ther
Lyu YS, Ahn H, Hong S, Park CY.
europepmc   +1 more source